Mark Agnel Frederick Dawson, Cigall Kadoch, Michelle Monje receive MSK’s 2023 Paul Marks Prize

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Mark Agnel Frederick Dawson

Cigall Kadoch

Michelle Monje

Memorial Sloan Kettering Cancer Center has named three innovative investigators as the recipients of this year’s Paul Marks Prize for Cancer Research. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

The long-awaited results from the RASolute 302 trial—a phase III clinical trial evaluating daraxonrasib, a RAS inhibitor, for the treatment of patients with previously treated, metastatic pancreatic ductal adenocarcinoma—have been read out. 
Christian Hinrichs, co-director of the Duncan and Nancy MacMillan Cancer Immunology and Metabolism Center of Excellence and chief of the Section of Cancer Immunotherapy, RWJBarnabas Health, has been awarded a four-year, $800,000 translational research grant from the V Foundation for Cancer Research to develop next-generation immunotherapies for cancers caused by human papillomavirus. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login